The Spanish Health Ministry is to monitor the 1,300 doctors across the country who prescribe the most, and is to revise eight million prescriptions through its health service Insalud, reports the Spanish financial daily Cinco Dias.
Insalud will implement monitoring through 42 pharmaceutical inspectors. The move is one of five programs that make up Insalud's pharmacy inspection plan. One of the objectives is to detect irregularities in pensioners' prescriptions, a sector which represents 65% of total prescriptions. Furthermore, the expenditure by this sector of the population on pharmaceutical products has risen 50% in the past 10 years.
The prescriptions to be revised are those improperly or illegally dispensed by pharmacies, and which relate to products that are excluded from reimbursement. Also, committees have been set up to monitor the use of interferon beta and human growth hormone in Spain, and plot the evolution of expenditure for these products.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze